The validity of sequence symmetry analysis (SSA) for adverse drug reaction signal detection

Pharmacoepidemiology and Drug Safety

Volumn 22, Issue 5, 2013, Pages 496-502

  Wahab, Izyan A ^a   Pratt, Nicole L ^a   Wiese, Michael D ^a   Kalisch, Lisa M ^a   Roughead, Elizabeth E ^a  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

Pharmacoepidemiology; Predictive values; Sensitivity; Sequence symmetry analysis; Specificity

Indexed keywords

ARTICLE; CONSENSUS DEVELOPMENT; CONTROLLED STUDY; DATA EXTRACTION; FOOD AND DRUG ADMINISTRATION; GOLD STANDARD; HUMAN; MAJOR CLINICAL STUDY; MEDICAL INFORMATION; PREDICTIVE VALUE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCIENTIST; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; SEQUENCE SYMMETRY ANALYSIS; SIGNAL DETECTION; VALIDATION STUDY;

ADVERSE DRUG REACTION REPORTING SYSTEMS; DATABASES, FACTUAL; HUMANS; PHARMACEUTICAL PREPARATIONS; PHARMACOVIGILANCE; PREDICTIVE VALUE OF TESTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SENSITIVITY AND SPECIFICITY; TIME FACTORS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84877629294     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.3417     Document Type: Article

References (22)

1. Petri H, Vet HCWD, Naus J, Urquhart J. Prescription sequence analysis: A new and fast method for assessing certain adverse reactions of prescription drugs in large populations. Stat Med 1988; 7(11): 1171-1175. DOI: 10.1002/sim.4780071110.
2. Hallas J. Evidence of depression provoked by cardiovascular medication: A prescription sequence symmetry analysis. Epidemiology 1996; 7(5): 478-484.
3. Lindberg G, Hallas J. Cholesterol-lowering drugs and antidepressants - A study of prescription symmetry. Pharmacoepidemiol Drug Saf 1998; 7(6): 399-402. DOI: 10.1002/(SICI)1099-1557.
4. Bytzer P, Hallas J. Drug-induced symptoms of functional dyspepsia and nausea. A symmetry analysis of one million prescriptions. Aliment Pharmacol Ther 2000; 14(11): 1479-1484. DOI: 10.1046/j.1365-2036.2000.00862.x.
5. Hersom K, Neary MP, Levaux HP, Klaskala W, Strauss JS. Isotretinoin and antidepressant pharmacotherapy: A prescription sequence symmetry analysis. J Am Acad Dermatol 2003; 49(3): 424-432. DOI:10.1067/S0190-9622(03)02087-5.
6. Corrao G, Botteri E, Bagnardi V, et al. Generating signals of drug-adverse effects from prescription databases and application to the risk of arrhythmia associated with antibacterials. Pharmacoepidemiol Drug Saf 2005; 14(1): 31-40. DOI: 10.1002/pds.1019.
7. Silwer L, Petzold M, Hallas J, Lundborg CS. Statins and nonsteroidal anti-inflammatory drugs-an analysis of prescription symmetry. Pharmacoepidemiol Drug Saf 2006; 15(7): 510-511. DOI: 10.1002/pds.1250.
8. Tsiropoulos I, Andersen M, Hallas J. Adverse events with use of antiepileptic drugs: A prescription and event symmetry analysis. Pharmacoepidemiol Drug Saf 2009; 18(6): 483-491. DOI: 10.1002/pds.1736.
9. Vegter S, De Jong-Van Den Berg LTW. Misdiagnosis and mistreatment of a common side-effect - Angiotensin-converting enzyme inhibitor-induced cough. Br J Clin Pharmacol 2010; 69(2): 200-203. DOI: 10.1111/j.1365-2125.2009.03571.x.
10. Garrison SR, Dormuth CR, Morrow RL, Carney GA, Khan KM. Nocturnal Leg Cramps and Prescription Use That Precedes Them: A Sequence Symmetry Analysis. Arch Intern Med 2012; 172(2): 120-126. DOI:10.1001/archinternmed.2011.1029.
11. Caughey GE, Roughead EE, Pratt N, Killer G, Gilbert AL. Stroke risk and NSAIDs: An australian population-based study. Med. J. Aust. 2011; 195(9): 525-529. DOI: 10.5694/mja11.10055.
12. Caughey GE, Roughead EE, Pratt N, Shakib S, Vitry AI, Gilbert AL. Increased risk of hip fracture in the elderly associated with prochlorperazine: is a prescribing cascade contributing? Pharmacoepidemiol Drug Saf 2010; 19(9): 977-982. DOI: 10.1002/pds.2009.
13. Australian Government Department of Veterans' Affairs. Treatment population statistics. Quarterly Report-March, 2011. http://www.dva.gov.au/aboutDVA/Statistics/Documents/TpopMar2011.pdf [27 July 2011].
14. World Health Organization Collaborating Centre for Drug Statistics Methodology. Anatomical Therapeutic Chemical Code Classification/Defined Daily Dose Index, 2011. http://www.whocc.no/atc_ddd_index/ [27 July 2011].
15. Australian Government, Department of Health and Ageing. Schedule of Pharmaceutical Benefits. PBS for health professional, 2011. http://www.pbs.gov.au/info/healthpro/explanatory-notes/section1/Section_1_2_Explanatory_Notes [27 July 2011].
16. National Centre for Classification in Health. International statistical classification of diseases and related health problems, Tenth Revision, Australian Modification (ICD-10-AM). National Centre for Classification in Health, Faculty of Health Sciences, University of Sydney, 2004.
17. Pharmaceutical Benefit Scheme. Expenditure and prescriptions twelve months to 30 June 2010. http://www.health.gov.au/internet/main/publishing.nsf/Content/4A3477B8447EC695CA25788600037450/$File/Expenditure%20and%20prescriptions%2012%20months%20to%2030%20June%202010.pdf [27 July 2011].
18. Matsushita Y, Kuroda Y, Niwa S, Sonehara S, Hamada C, Yoshimura I. Criteria Revision and Performance Comparison of Three Methods of Signal Detection Applied to the Spontaneous Reporting Database of a Pharmaceutical Manufacturer. Drug Saf 2007; 30(8): 715-726.
19. Choi N-K, Chang Y, Kim J-Y, Choi Y-K, Park B-J. Comparison and validation of data-mining indices for signal detection: using the Korean national health insurance claims database. Pharmacoepidemiol Drug Saf 2011; 20(12): 1278-1286. DOI: 10.1002/pds.2237.
20. Lehman HP, Chen J, Gould AL, et al. An Evaluation of Computer-Aided Disproportionality Analysis for Post-Marketing Signal Detection. Clin Pharmacol Ther 2007; 82(2): 173-180. DOI:10.1038/sj.clpt.6100233.
21. Lindquist M, Stahl M, Bate A, Edwards IR, Meyboom RHB. A retrospective evaluation of a data mining approach to aid finding new adverse drug reaction signals in the WHO international database. Drug Saf 2000; 23(6): 533-542.
22. The Uppsala Monitoring Centre. The Use of the WHO-UMC system for standardised case causality assessment. http://who-umc.org/Graphics/24734.pdf [13 December 2012].